Intus Bio's Titan-1 platform is powering a microbiome revolution, by unlocking insights into the role of bacteria across health ouctomes
Intus Bio has raised $1.1M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in May 2025.
Intus Bio's investors include Connecticut Innovations, UConn Innovation Fund - University of Connecticut.
Intus Bio is headquartered in Farmington, United States.
Intus Bio's Titan-1 platform is powering a microbiome revolution, by unlocking insights into the role of bacteria across health ouctomes
Intus Bio is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Intus Bio — Funding & Investors." VCBacked, May 27, 2025, https://www.vcbacked.co/company/intus-bio. Accessed July 20, 2026.
VCBacked. (2025). Intus Bio — Funding & Investors. Retrieved July 20, 2026, from https://www.vcbacked.co/company/intus-bio
{{cite web |title=Intus Bio — Funding & Investors |url=https://www.vcbacked.co/company/intus-bio |website=VCBacked |access-date=July 20, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated